心臟瓣膜市場規模、佔有率和成長分析（按類型、地點、治療方法、最終用戶和地區分類）—2026-2033年產業預測

預計到 2024 年，全球心臟瓣膜市場規模將達到 95.8 億美元，到 2025 年將達到 106.7 億美元，到 2033 年將達到 253.1 億美元，在預測期（2026-2033 年）內，複合年成長率為 11.4%。

全球心臟瓣膜市場正經歷變革時期，其驅動力主要來自心血管疾病（尤其是心臟衰竭）治療技術的進步。隨著心臟病盛行率的上升，人們越來越關注能夠改善治療效果的創新解決方案。主要產業參與者推出的尖端產品將改善治療調查方法並推動進一步發展，預計該市場將顯著成長。全球心血管疾病患者人數的不斷增加是這項擴張的關鍵因素。瓣膜疾病和冠狀動脈疾病發生率的上升正在推動對心臟瓣膜置換術對於恢復最佳心臟功能和改善患者整體預後至關重要。

全球心臟瓣膜市場成長要素

全球心臟瓣膜市場的成長主要受人口老化和久坐生活方式趨勢的驅動。這些因素導致心臟瓣膜疾病的盛行率不斷上升，增加了對有效治療方法的需求。心臟瓣膜設計和手術技術的進步也是推動該市場發展的關鍵因素。此外，微創手術方案的日益普及進一步提高了人們對心臟瓣膜疾病手術治療的認知度和接受度，縮短了患者的復健時間，改善了整體治療效果。

全球心臟瓣膜市場面臨的限制因素

全球心臟瓣膜市場面臨嚴峻挑戰，這主要歸因於各國政府對醫療產品（尤其是心臟瓣膜）的研發、生產和應用實施的嚴格監管。這些法規結構要求流程複雜且耗時，需要進行廣泛的測試並提交詳盡的文檔，以確保器械的安全性和有效性。這種高度嚴格的審查可能會抑制創新並減緩市場成長，因為製造商必須投入大量時間和資源來滿足合規要求，而且核准流程也可能出現延誤。因此，這種監管環境有可能阻礙新型心臟瓣膜解決方案的及時上市。

全球心臟瓣膜市場趨勢

由於心臟瓣膜疾病盛行率不斷上升，以及技術進步催生出創新型心臟瓣膜裝置，全球心臟瓣膜市場正經歷顯著成長。大量患者面臨諸如風濕性心臟病等可能導致嚴重併發症的疾病，這加速了對有效治療方案的需求。此外，獲得監管部門核准的新型改良裝置不斷湧現，為製造商創造了機遇，加劇了市場競爭，並推動了產品品質和療效的提升。這些因素共同造就了一個不斷擴張且充滿活力的市場，旨在滿足全球迫切的醫療需求。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管環境
• 案例研究
• 技術進步

全球心臟瓣膜市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 經導管心臟瓣膜
• 生物瓣膜
• 機械心臟瓣膜
• 其他

全球心臟瓣膜市場規模（按地區分類）及複合年成長率（2026-2033 年）

• 二尖瓣
• 主動脈瓣
• 其他部分

全球心臟瓣膜市場規模（依治療方法分類）及複合年成長率（2026-2033 年）

• 心臟瓣膜修復
• 心臟瓣膜置換術

全球心臟瓣膜市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 心臟研究所
• 醫院和診所
• 專業中心
• 其他

全球心臟瓣膜市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Medtronic（Ireland）
• Edwards Lifesciences（United States）
• Boston Scientific（United States）
• Abbott Laboratories（United States）
• LivaNova（United Kingdom）
• CryoLife（United States）
• MicroPort Scientific（China）
• Braile Biomedica（Brazil）
• TTK Healthcare（India）
• Colibri Heart Valve（United States）
• Venus Medtech（China）
• Peijia Medical（China）
• Lepu Medical Technology（China）
• Meril Life Sciences（India）
• Biotronik（Germany）
• Neovasc（Canada）
• Cardiac Dimensions（United States）
• HighLife Medical（France）
• Mardil Medical（United States）

結論與建議

Global Cardiac Valve Market size was valued at USD 9.58 Billion in 2024 and is poised to grow from USD 10.67 Billion in 2025 to USD 25.31 Billion by 2033, growing at a CAGR of 11.4% during the forecast period (2026-2033).

The global cardiac valve market is undergoing a transformative phase driven by technological advancements in the management of cardiovascular diseases, particularly heart failure. As the prevalence of cardiac conditions rises, there is a heightened focus on innovative solutions to improve treatment outcomes. The market is poised for significant growth, propelled by the introduction of cutting-edge products from major industry players, which will enhance treatment methodologies and drive further advancements. A critical factor in this expansion is the increasing global population affected by various cardiovascular issues. The growing incidence of conditions such as valvular disorders and coronary artery disease has led to a heightened demand for cardiac valve replacements, which are essential in restoring optimal cardiac function and improving overall patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Valve market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Valve Market Segments Analysis

Global Cardiac Valve Market is segmented by Type, Position, Treatment, End User and region. Based on Type, the market is segmented into Trans-Catheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve and Others. Based on Position, the market is segmented into Mitral Valve, Aortic Valve and Other Position. Based on Treatment, the market is segmented into Cardiac Valve Repair and Cardiac Valve Replacement. Based on End User, the market is segmented into Cardiac Research Institute, Hospital and Clinics, Speciality centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Valve Market

The growth of the global cardiac valve market is primarily fueled by the rising elderly population and a trend toward more sedentary lifestyles. These factors contribute to a higher prevalence of heart valve diseases, intensifying the demand for effective treatments. Technological advancements in heart valve design and procedures also play a crucial role in driving this market forward. Additionally, there is an increasing emphasis on minimally invasive surgical options, which enhances patient recovery times and overall outcomes, further encouraging awareness and acceptance of surgical interventions in the management of heart valve issues.

Restraints in the Global Cardiac Valve Market

The Global Cardiac Valve market faces significant challenges stemming from stringent government regulations that oversee the development, production, and application of medical products, particularly cardiac valves. These regulatory frameworks demand a complex and labor-intensive process that requires extensive testing and comprehensive documentation to ensure the safety and efficacy of these devices. This high level of scrutiny can impede innovation and slow down the market's growth, as manufacturers must allocate considerable time and resources to meet compliance requirements while also dealing with potential delays in the approval process. Consequently, this regulatory landscape can hinder the timely availability of new cardiac valve solutions.

Market Trends of the Global Cardiac Valve Market

The Global Cardiac Valve market is witnessing substantial growth driven by a combination of rising prevalence of heart valve diseases and advancements in technology that yield innovative cardiac valve devices. As a significant number of individuals face conditions such as rheumatic heart disease, which can lead to severe complications, the demand for effective treatment solutions is accelerating. Additionally, the emergence of new, enhanced devices that receive regulatory approvals is creating opportunities for manufacturers, fostering competition and driving improvements in quality and efficacy. This confluence of factors highlights a dynamic market poised for expansion, aimed at addressing urgent healthcare needs globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Cardiac Valve Market Size by Type & CAGR (2026-2033)

• Market Overview
• Trans-Catheter Heart Valve
• Tissue Heart Valve
• Mechanical Heart Valve
• Others

Global Cardiac Valve Market Size by Position & CAGR (2026-2033)

• Market Overview
• Mitral Valve
• Aortic Valve
• Other Position

Global Cardiac Valve Market Size by Treatment & CAGR (2026-2033)

• Market Overview
• Cardiac Valve Repair
• Cardiac Valve Replacement

Global Cardiac Valve Market Size by End User & CAGR (2026-2033)

• Market Overview
• Cardiac Research Institute
• Hospital and Clinics
• Speciality centers
• Others

Global Cardiac Valve Market Size & CAGR (2026-2033)

• North America (Type, Position, Treatment, End User)
  • US
  • Canada
• Europe (Type, Position, Treatment, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Position, Treatment, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Position, Treatment, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Position, Treatment, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK Healthcare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colibri Heart Valve (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Medtech (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Peijia Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neovasc (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Dimensions (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HighLife Medical (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mardil Medical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations